Skip to content
PubMed This is a summary of 70 peer-reviewed journal articles Updated
Ophthalmology

Scleromalacia Perforans: A Patient Guide

At a Glance

Scleromalacia perforans is a rare, often painless form of scleritis that thins the eye’s outer wall and may be linked to rheumatoid arthritis or vasculitis. Prompt eye and rheumatology care, regular imaging, immune treatment, and grafts when needed help protect the eye.

Scleromalacia perforans is a rare and unique condition that changes the way we think about eye health. While many forms of scleritis announce themselves with intense pain and redness, this specific form of necrotizing anterior scleritis is “quiet.” It causes the white wall of the eye (the sclera) to thin and lose tissue without the typical warning signs of inflammation [1][2]. Because it is painless, you may first notice the condition simply by looking in the mirror and seeing a dark bluish or gray tint where your eye was once white—a change caused by the dark inner structures of the eye becoming visible through the thinning sclera [3][4].

What I Should Do Now: The absence of pain does not mean the eye is stable. Any visible change or suspected diagnosis requires prompt specialist follow-up even when the eye feels comfortable. Contact your eye specialist immediately if you notice new redness, pain, discharge, trauma, or vision changes.

The scleral thinning is often not an isolated event; it can be a signal that the immune system is overactive. There is a very strong connection between scleromalacia perforans and long-standing rheumatoid arthritis, as well as other systemic conditions like vasculitis, though it can occur without an identified systemic disease [5][6]. In these cases, the same biological processes that affect the joints or blood vessels begin to dissolve the collagen fibers that give the eye its strength. Because of this deep connection, managing the condition requires a “team” approach, where an eye specialist (like a uveitis or cornea expert) works closely with a rheumatologist to treat the underlying cause [7].

Because you cannot rely on pain to tell you if the condition is getting worse, monitoring becomes a matter of objective measurements. Doctors use clinical examinations, visual acuity, serial photographs, and advanced imaging such as Anterior-Segment OCT, to map the thickness of the eye wall and look for signs of ectasia (bulging) or impending structural failure [8][9]. These regular checks are vital because they allow your care team to intervene before the thinning leads to a globe perforation, which is a full-thickness opening in the eye wall that can threaten your vision [3][10].

Treatment for scleromalacia perforans is focused on both biology and structure. The medical side involves systemic immunosuppression—medications prescribed by your specialists to calm the immune attack and slow tissue loss [7][11]. If the eye wall becomes dangerously thin, a surgical side comes into play, involving tectonic grafts or patches to physically reinforce the eye and aim to preserve its integrity [12][13]. By combining these medical and surgical strategies with consistent monitoring, the goal is to stabilize the eye wall, protect your globe, and manage the systemic health that drives these changes.

Common questions in this guide

What is scleromalacia perforans, and why might it not hurt?
Scleromalacia perforans is a rare form of scleritis in which the white outer wall of the eye becomes thin and loses tissue. Unlike many types of scleritis, it may cause little or no pain or redness, and a dark bluish or gray area may be the first visible sign.
What health conditions are associated with scleromalacia perforans?
Scleromalacia perforans is strongly associated with long-standing rheumatoid arthritis and can also occur with vasculitis or other immune-related diseases. Sometimes doctors do not find an underlying systemic condition, so evaluation by a rheumatologist may still be useful.
How do doctors monitor painless scleral thinning?
Eye specialists use examinations, visual acuity testing, serial photographs, and imaging such as anterior-segment optical coherence tomography, or AS-OCT. These checks measure changes in the eye wall and look for bulging or signs that the eye may be at risk of perforation.
How is scleromalacia perforans treated?
Treatment usually addresses the immune process with systemic immunosuppressive medicines prescribed by the care team. If the eye wall becomes dangerously thin, a tectonic graft or patch may be used to reinforce it, while an ophthalmologist and rheumatologist coordinate care.
What changes should prompt urgent medical attention?
New redness, eye pain, discharge, an eye injury, or any change in vision should prompt immediate contact with an eye specialist. Because scleromalacia perforans can worsen without pain, a comfortable eye does not necessarily mean the condition is stable.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my clinical presentation, are we certain this is the painless 'scleromalacia perforans' form of scleritis?
  2. 2.How often will we perform structural imaging like AS-OCT to check for thinning I can't feel?
  3. 3.Who is the rheumatologist on my care team, and how frequently will you be communicating with them?
  4. 4.What specific visual changes should I consider an emergency, given that I won't have pain as a warning sign?
  5. 5.Are we currently treating the underlying 'autoimmune fire' or just the structural changes in my eye?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Sclerokeratitis and Secondary Glaucoma in Relapsing Polychondritis in a 30-Year-Old Asian Male Patient: A Case Report.

    Flores LKC, Siazon RR

    Cureus 2025; (17(2)):e79128 doi:10.7759/cureus.79128.

    PMID: 40109806
  2. 2

    [Diagnostic and Therapeutic Management of Episcleritis and Scleritis].

    Turgut F, Dingerkus V, Tappeiner C, Becker M

    Klinische Monatsblatter fur Augenheilkunde 2023; (240(5)):725-738 doi:10.1055/a-2022-0689.

    PMID: 36827997
  3. 3

    Scleromalacia perforans: a case report.

    Ghauri MI, Riaz SU, Husain A, et al.

    Journal of medical case reports 2018; (12(1)):155 doi:10.1186/s13256-018-1686-z.

    PMID: 29866188
  4. 4

    Spontaneous Descemet Membrane Detachment After Necrotizing Scleritis: A Case Report.

    Margulies KS, Kiavash V, Syed ZA

    Cornea 2026; (45(2)):239-242 doi:10.1097/ICO.0000000000003930.

    PMID: 40600595
  5. 5

    Case of isolated scleromalacia perforans with seropositivity for rheumatoid arthritis.

    Hajizadeh S, O'Donnell C, Dore A

    BMJ case reports 2024; (17(6)) doi:10.1136/bcr-2024-259863.

    PMID: 38925670
  6. 6

    ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome.

    Perray L, Nguyen Y, Clavel Refregiers G, et al.

    Rheumatology (Oxford, England) 2024; (63(2)):329-337 doi:10.1093/rheumatology/kead252.

    PMID: 37233203
  7. 7

    Necrotizing Scleritis: A Review.

    Dutta Majumder P, Agarwal S, Shah M, et al.

    Ocular immunology and inflammation 2024; (32(7)):1405-1419 doi:10.1080/09273948.2023.2206898.

    PMID: 37279404
  8. 8

    Case Report: Subconjunctival Triamcinolone Acetate-associated Scleral Necrosis: Is It Really Obsolete?

    Agarwal R, Bafna RK, Chetan C, Sharma N

    Optometry and vision science : official publication of the American Academy of Optometry 2021; (98(9)):1016-1020 doi:10.1097/OPX.0000000000001761.

    PMID: 34433205
  9. 9

    Anterior segment spectral domain optical coherence tomography imaging of patients with anterior scleritis.

    Levison AL, Lowder CY, Baynes KM, et al.

    International ophthalmology 2016; (36(4)):499-508 doi:10.1007/s10792-015-0153-8.

    PMID: 26597942
  10. 10

    Scleral Patch Graft With a Suture Reinforcement Technique in Surgical Management of Necrotizing Scleritis With Ectasia.

    Wen JC, Lam J, Banitt MR

    Cornea 2018; (37(7)):933-935 doi:10.1097/ICO.0000000000001598.

    PMID: 29664747
  11. 11

    Clinical Profile of Patients with Necrotizing Scleritis in a Tertiary Eye Care Center in Southern India.

    Dutta Majumder P, Ghose A, Chidambaram M, et al.

    Ocular immunology and inflammation 2018; (26(3)):412-416 doi:10.1080/09273948.2016.1223857.

    PMID: 27762661
  12. 12

    Transplantation of autologous perichondrium with amniotic membrane for progressive scleral necrosis.

    Kim JT, Kim KW, Mun SK, et al.

    The ocular surface 2019; (17(3)):571-577 doi:10.1016/j.jtos.2019.05.004.

    PMID: 31112741
  13. 13

    Combined Tenonplasty and Scleral Graft for Refractory Pseudomonas Scleritis Following Pterygium Removal with Mitomycin C Application.

    Siatiri H, Mirzaee-Rad N, Aggarwal S, Kheirkhah A

    Journal of ophthalmic & vision research 2018; (13(2)):200-202 doi:10.4103/jovr.jovr_122_16.

    PMID: 29719651

This page is for informational purposes only and does not constitute medical advice. It cannot replace evaluation by your eye specialist and rheumatologist, especially if you notice eye or vision changes.

Get notified when new evidence is published on scleromalacia perforans.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.